Singapore is a recognized destination for clinical trials with multi-ethnic populations.

George Clinical In Singapore

Singapore is a recognized destination for clinical trials with multi-ethnic populations including 74% Chinese, 13% Malay and 9% Indian.

Similarly, to what George Clinical provides in Hong Kong and Taiwan, Singapore offers regulatory services which includes acting as local sponsor while managing IP importations, project management, safety and pharmacovigilance (PV) reporting services.

Key advantages of conducting clinical trials with George Clinical in Singapore include a well-established regulatory and ethics review framework; fast approval due to HSA adopting a risk-based approach in the regulations of clinical trials of therapeutic products; and paperless submissions. Commercially, clients also have the convenience of doing business in the Asian market where English is the official language.


What are the benefits of conducting clinical trials in Singapore?

    • Short start up timeline of 3-4 months
    • Well established RA and EC framework
    • Majority of institutions have clinical trial centers which can assist in the set-up and coordination of clinical trials
    • High quality data and experienced GCP trained clinical trial staffs

What are the prevalent diseases in Singapore?

  1. Cancer
  2. Cardiovascular diseases
  3. Neurological, vision/hearing and other sense disorders
  4. Mental and substance abuse disorders
  5. Musculoskeletal disorders
  6. Injuries
  7. Lower respiratory infections
  8. Chronic respiratory diseases
  9. Chronic kidney disease


Our People in Singapore are Experienced in

Cardiovascular 83%

Central Nervous System 17%

Endocrinology 100%

Oncology 67%

Respiratory 50%

Nephrology 100%


George Clinical Address:
80 Robinson Road, #02-00,
Singapore, 068898

Phone: +852 3104 2720


Population 5,638,700
Official Language English, Chinese, Malay and Tamil
Hospital Records Language English
Electronic Hospital Records All Singapore hospitals utilize a standard form of electronic medical records
In-country services Regulatory Services
Project Management
Clinical Operations
Act as Local Sponsor
Import/Export Study Supplies
GDP – per capita (US $) $72,285
Health Expenditures 3.5% of GDP

Add George Clinical to your network